KLTO
Price
$0.72
Change
-$0.53 (-42.40%)
Updated
Jun 27 closing price
Capitalization
26.28M
PBM
Price
$4.91
Change
-$0.20 (-3.91%)
Updated
Jun 27 closing price
Capitalization
2.86M
Interact to see
Advertisement

KLTO vs PBM

Header iconKLTO vs PBM Comparison
Open Charts KLTO vs PBMBanner chart's image
Klotho Neurosciences
Price$0.72
Change-$0.53 (-42.40%)
Volume$8.34M
Capitalization26.28M
Psyence Biomedical
Price$4.91
Change-$0.20 (-3.91%)
Volume$9.18K
Capitalization2.86M
KLTO vs PBM Comparison Chart in %
Loading...
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KLTO vs. PBM commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLTO is a Buy and PBM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (KLTO: $0.72 vs. PBM: $4.91)
Brand notoriety: KLTO and PBM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KLTO: 29% vs. PBM: 7%
Market capitalization -- KLTO: $26.28M vs. PBM: $2.86M
KLTO [@Biotechnology] is valued at $26.28M. PBM’s [@Biotechnology] market capitalization is $2.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KLTO’s FA Score shows that 0 FA rating(s) are green whilePBM’s FA Score has 1 green FA rating(s).

  • KLTO’s FA Score: 0 green, 5 red.
  • PBM’s FA Score: 1 green, 4 red.
According to our system of comparison, PBM is a better buy in the long-term than KLTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KLTO’s TA Score shows that 6 TA indicator(s) are bullish while PBM’s TA Score has 2 bullish TA indicator(s).

  • KLTO’s TA Score: 6 bullish, 4 bearish.
  • PBM’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, KLTO is a better buy in the short-term than PBM.

Price Growth

KLTO (@Biotechnology) experienced а -53.24% price change this week, while PBM (@Biotechnology) price change was +3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KLTO($26.3M) has a higher market cap than PBM($2.86M). KLTO YTD gains are higher at: 48.474 vs. PBM (-70.803). PBM has more cash in the bank: 1.93M vs. KLTO (566K). KLTO has less debt than PBM: KLTO (1.77M) vs PBM (2.5M).
KLTOPBMKLTO / PBM
Capitalization26.3M2.86M918%
EBITDA-6.8MN/A-
Gain YTD48.474-70.803-68%
P/E RatioN/A0.12-
Revenue0N/A-
Total Cash566K1.93M29%
Total Debt1.77M2.5M71%
TECHNICAL ANALYSIS
Technical Analysis
KLTOPBM
RSI
ODDS (%)
Bearish Trend 4 days ago
12%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
52%
Bullish Trend 4 days ago
69%
Momentum
ODDS (%)
Bearish Trend 4 days ago
63%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
38%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
67%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
25%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 21 days ago
60%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
17%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIAV10.000.08
+0.81%
Viavi Solutions
WASH28.250.08
+0.28%
Washington Trust Bancorp
QLGN3.550.01
+0.28%
Qualigen Therapeutics Inc
RIVN13.60-0.16
-1.16%
Rivian Automotive
SOTK3.63-0.11
-2.94%
Sono-Tek Corp

KLTO and

Correlation & Price change

A.I.dvisor tells us that KLTO and CTXR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KLTO and CTXR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLTO
1D Price
Change %
KLTO100%
-42.39%
CTXR - KLTO
31%
Poorly correlated
N/A
ANIX - KLTO
28%
Poorly correlated
-4.73%
KALA - KLTO
27%
Poorly correlated
-12.08%
GUTS - KLTO
26%
Poorly correlated
-5.75%
PBM - KLTO
25%
Poorly correlated
-3.89%
More

PBM and

Correlation & Price change

A.I.dvisor tells us that PBM and ATHA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBM and ATHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBM
1D Price
Change %
PBM100%
-3.89%
ATHA - PBM
30%
Poorly correlated
-2.64%
SLRX - PBM
29%
Poorly correlated
-0.01%
MNMD - PBM
27%
Poorly correlated
-2.82%
CRBU - PBM
26%
Poorly correlated
-6.67%
PRME - PBM
25%
Poorly correlated
-8.68%
More